SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG
0
Add to list
GB COVID-19 Ag POCT
Cat. No. 4ECO101E
More details>
(3 items)
SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG About GBC Our Brands R&D Media Join us Contact us
English 繁體中文
Menu
Pharma
Diagnostic Solutions
Our goal is to make people’s health better
What we do here every day is important.
Candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Candida normally lives on the skin and inside the body in places such as the mouth, throat, gut, and vagina without causing any problems. A person’s immune system can become weakened, however, if antibiotics affect the natural balance of microbes in the body.
P113 AMP (antimicrobial peptide) is believed to have the potential to prevent candidiasis infection, including both oral and vaginal candidiasis.
Key Attributes
Pipeline
P113
Generic Name Phase 1 2 3 F
P113
Application
New Drug
Indication
Oral Candidiasis
Swipe left to view all
Diagnostic Solution
We develop and manufacture diagnostic tests, instruments, and digital solutions designed to fundamentally improve people’s health.
In Vitro Diagnostics (IVD)
Since 1984, we’ve been developing hepatitis and retrovirus in vitro diagnostics and expanding our research into conditions such as cancers, infectious diseases, COVID-19, and many others.

In vitro diagnostics are vital tools for doctors when it comes to treating and preventing major illnesses. Utilizing technologies such as RIA, ELISA and Real-Time PCR, we create precision diagnostics tools, working side-by-side with pharmaceutical companies.
Systems
We have launched several instruments that work in conjunction with our in vitro diagnostics. These automated systems allow lab technicians to gain fast, reliable and consistent results without consuming substantial amounts of a technician’s time.
Our Products
Diagnostic Solutions